Vimarsana
Biggest News Aggregation in the World

Page 5 - Zyme Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Zyme Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Zyme Communications Today - Breaking & Trending Today

SolasCure Announces Final Closing of GBP 10.9m (c. USD 13.3m) Series B Fundraise to Advance Wound Care Innovation - Vimarsana News

SolasCure Announces Final Closing of GBP 10.9m (c. USD 13.3m) Series B Fundraise to Advance Wound Care Innovation

Funding will support the development of Aurase Wound Gel and progress toward further Phase II clinical trials of innovative wound debriding enzyme SOLASCURE Ltd (SolasCure), a biotechnology company

Gyros Protein Technologies Introduces New PurePep EasyClean Services to Accelerate Development and Manufacturing of Peptide-based Drugs - Vimarsana News

Gyros Protein Technologies Introduces New PurePep EasyClean Services to Accelerate Development and Manufacturing of Peptide-based Drugs

Services support peptide purification, custom synthesis of PEC-grade peptides, and development and production of peptide drugs and drug candidates PurePep EasyClean (PEC) orthogonal purification

Investegate |Avacta Group PLC Announcements | Avacta Group PLC: Issue of Equity and Total Voting Rights - Vimarsana News

Investegate |Avacta Group PLC Announcements | Avacta Group PLC: Issue of Equity and Total Voting Rights

Investegate announcements from Avacta Group PLC, Issue of Equity and Total Voting Rights

Evonetix Closes $24 Million USD (£20 Million) Financing - Vimarsana News

Evonetix Closes $24 Million USD (£20 Million) Financing

Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale EVONETIX LTD ('Evonetix'), the synthetic biology company

Orbit Discovery and Endevica Bio Enter Multi-target Collaboration to Advance Development of Cachexia Therapeutics - Vimarsana News

Orbit Discovery and Endevica Bio Enter Multi-target Collaboration to Advance Development of Cachexia Therapeutics

Orbit Discovery Limited (Orbit), a leader in the discovery of therapeutic peptide hits, today announced it has entered into a multi target Research Agreement with Endevica Bio Inc., (Endevica), a company